Complex Decision Making for Individual Patients With Penile Cancer: Benchmarking Divergent Practices in European High-Volume Reference Centers: Results From eUROGEN Survey
- 22 November 2024
- journal article
- Published by Elsevier in Clinical Genitourinary Cancer
- Vol. 23 (1) , 102275
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Adherence to European Association of Urology and National Comprehensive Cancer Network Guidelines Criteria for Inguinal and Pelvic Lymph Node Dissection in Penile Cancer Patients—A Survey Assessment in German-speaking Countries on Behalf of the European Prospective Penile Cancer Study GroupEuropean Urology Focus, 2021
- Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignanciesCancer, 2020
- Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working GroupAnnals of Oncology, 2020
- Adherence to the EAU guideline recommendations for systemic chemotherapy in penile cancer: results of the E-PROPS study group surveyWorld Journal of Urology, 2019
- The International Penile Advanced Cancer Trial (InPACT): Rationale and Current StatusEuropean Urology Focus, 2019
- Making surgery safer by centralization of care: impact of case load in penile cancerWorld Journal of Urology, 2019
- Impact of Centralizing Care for Genitourinary Malignancies to High-volume Providers: A Systematic ReviewEuropean Urology Oncology, 2019
- Adherence to EAU guidelines on penile cancer translates into better outcomes: a multicenter international studyWorld Journal of Urology, 2018
- Treatment Trends and Outcomes for Patients With Lymph Node–Positive Cancer of the PenisJAMA Oncology, 2018
- Neoadjuvant Taxane-Based Combination Chemotherapy in Patients With Advanced Penile CancerClinical Genitourinary Cancer, 2015